Spinal Elements, Inc. Receives FDA 510(k) Market Clearance for its Lucent(R) Spinal Implants as a Lumbar Intervertebral Body Fusion Device (IBFD)

CARLSBAD, Calif.--(BUSINESS WIRE)--Spinal Elements, Inc. announced today the receipt of FDA 510(k) clearance to market the Lucent® Spinal Implants as lumbar intervertebral body fusion devices (IBFD). This clearance of the Lucent system enables surgeons to utilize this advanced implant and instrumentation technology for degenerative disc disease and other common spinal maladies.